Skip to content

The establishment of percutaneous transhepatic hepaticoenterostomy (I/II-level bile duct) channels for minimally invasive treatment research of hepatic duct stenosis/obstruction at the hepatic hilum

The establishment of percutaneous transhepatic hepaticoenterostomy (I/II-level bile duct) channels for minimally invasive treatment research of hepatic duct stenosis/obstruction at the hepatic hilum

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077293
Enrollment
Unknown
Registered
2023-11-03
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic duct stenosis/obstruction at the hepatic hilum

Interventions

exposure group (ultrasound-guided percutaneous transhepatic cholangioscopy (PTCS) for the treatment of bile duct strictures at the hepatic hilum):None
control group (ultrasound-guided percutaneous transhepatic cholangioscopy (PTCS) for the treatment of bile duct strictures at the peripheral bile duct):None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Preoperative confirmation of biliary atresia (BA) or biliary stenosis (BS) through CT, magnetic resonance cholangiopancreatography (MRCP), and cholangiography examinations; 2.Age between 18 and 70 years old; 3.General good health, absence of significant organ structural damage or functional impairments, and the ability to tolerate general anesthesia and open surgery; 4.Preoperative liver function categorized as Child-Pugh Class A or Child-Pugh Class B; 5.Normal coagulation function; I6.nformed consent from the patient and their family members.

Exclusion criteria

Exclusion criteria: 1.Patients with significant organ structural damage and functional impairments who cannot tolerate general anesthesia and open surgery; 2.Preoperative liver function categorized as Child-Pugh Class C; 3.Abnormal coagulation function; 4.Patients requiring emergency surgery for acute obstructive suppurative cholangitis; 5.Patients with liver atrophy or intrahepatic bile duct carcinoma.

Design outcomes

Primary

MeasureTime frame
success rate of puncture;complication occurrence rate;residual stone rate;recurrence rate of hepatic duct stenosis/obstruction;hospitalization duration;inpatient expenses;

Countries

China

Contacts

Public ContactRongxing Zhou

West China Hospital, Sichuan University

rongxingzhou@126.com+86 189 8060 2218

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026